• Light-Inducible RNA Switches Enable Precise Gene Therapy Con

  2026-07-30

  A recent study introduces a rationally engineered, light-inducible RNA-releasing protein (LIRP) that allows reversible, spatiotemporal control of therapeutic gene expression in vivo. This innovation advances optogenetic gene therapy, enabling safer, on-demand interventions for chronic metabolic and retinal diseases.

• From Mechanism to Clinic: Annexin V-FITC/PI Apoptosis in Tra

  2026-07-30

  This article explores the pivotal role of apoptosis detection—particularly with the Annexin V-FITC/PI Apoptosis Assay Kit—in advancing translational research, using the lens of recent mechanistic findings in granulosa cell dysfunction in PCOS. It blends biological rationale, practical guidance, competitive context, and forward-looking insights, connecting robust assay methodology with impactful clinical questions.

• Berberine Modulates SASP Inflammation via RXRα/PPARγ/NEDD4 A

  2026-07-29

  This study demonstrates that berberine suppresses senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. These findings clarify a mechanistic link between PPARγ signaling and chronic vascular inflammation, offering new directions for targeted anti-atherosclerotic strategies.

• GSK J4 HCl: Driving Precision in JMJD3 Inhibition and Inflam

  2026-07-29

  GSK J4 HCl, a potent and cell-permeable JMJD3 inhibitor from APExBIO, is reshaping epigenetic regulation research by enabling targeted modulation of inflammatory pathways and chromatin remodeling. This thought-leadership article explores the underlying biological mechanisms, experimental evidence, and translational potential of GSK J4 HCl—particularly in the context of inflammatory disorder research and emerging pediatric brainstem glioma models—while offering strategic protocol guidance. By bridging landmark findings on H3K27 methylation and CXCL10 regulation at the maternal-fetal interface, this piece pushes beyond standard product discussions to chart new territory for translational researchers.

• iRhom2's Role in Olfactory Receptor Regulation and Sensory A

  2026-07-28

  Azzopardi et al. (2024) reveal that iRhom2 is selectively expressed in olfactory sensory neurons and mediates activity-dependent adaptation via ADAM17 signaling. This work identifies a feedback mechanism by which odor exposure modulates receptor gene expression, offering new insights for molecular studies of sensory plasticity.

• Br-DAPI: Next-Generation DAPI Fluorescent Dye for DNA Staini

  2026-07-28

  Br-DAPI sets a new benchmark for DNA quantification and live/fixed cell fluorescence microscopy. Its robust A/T-selectivity and 20-fold fluorescence amplification yield superior signal-to-noise, streamlining workflows and troubleshooting in demanding research applications.

• Proteoform-Specific Drug Targeting in Native Membrane Enviro

  2026-07-27

  This article explores a recent study that advances the direct characterization of proteoform-specific drug interactions in native cell signalling environments using native top-down mass spectrometry. The findings highlight the critical role of post-translational modifications in membrane protein–ligand interactions and reveal off-target effects of cGMP-specific phosphodiesterase type 5 inhibitors with retinal PDE6, informing future drug design.

• Smoothened Agonist Modulation of Olfactory Function in Honey

  2026-07-27

  Guo et al. (2024) provide the first molecular characterization of Smoothened (Smo) in Apis mellifera, uncovering its pivotal role in regulating olfactory receptor expression and behavior. The study uses pharmacological Smo modulation—specifically via Purmorphamine—to demonstrate a functional link between Hedgehog pathway activity and insect sensory systems, with broad relevance for both invertebrate and vertebrate research.

• Docosahexaenoic Acid (DHA) for Reliable Neuroprotection Rese

  2026-07-26

  This article examines how Docosahexaenoic Acid (DHA, SKU C4188) addresses common challenges in cell-based neuroprotection and viability assays. It offers scenario-driven answers grounded in recent literature and product data, highlighting robust experimental outcomes and workflow consistency for those using APExBIO’s DHA.

• Caspase-3 and ERO1α Drive Trichothecene-Induced Mitochondria

  2026-07-25

  This study uncovers how trichothecene mycotoxins, such as DON and T-2 toxin, induce hepatotoxicity through a caspase-3-dependent cleavage of mitochondrial NDUFS1 and activation of ER-localized ERO1α, resulting in excessive reactive oxygen species (ROS) accumulation. These findings clarify the mechanisms of mitochondrial dysfunction in toxin exposure and highlight actionable assay targets for redox biology research.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-24

  The referenced study reveals that HOXC8 inhibits pyroptotic cell death in non-small cell lung carcinoma by repressing caspase-1 expression through HDAC1/2-mediated chromatin regulation. These findings clarify the transcriptional control of inflammation-linked cell death in lung cancer and suggest new directions for targeting the caspase signaling pathway in oncology.

• 7-AAD Assays & CD38 Affinity Tuning: Blueprint for Safer CAR

  2026-07-24

  This article unpacks the intersection of molecular-level CAR-T engineering and advanced cell viability analytics, offering translational researchers a mechanistic and strategic guide to optimizing next-generation immunotherapies with the 7-AAD Cell Viability Assay Kit.

• GSK621 AMPK Agonist: Advanced Workflows for Metabolic Resear

  2026-07-23

  GSK621 is a next-generation AMPK agonist enabling robust apoptosis induction, metabolic pathway modulation, and autophagy enhancement, particularly in acute myeloid leukemia and immunometabolic studies. This guide translates recent mechanistic breakthroughs into actionable protocols and troubleshooting strategies, empowering reproducible results across advanced cell and in vivo models.

• Decitabine (5-Aza-2'-deoxycytidine) in Cancer Epigenetics Wo

  2026-07-23

  Decitabine (5-Aza-2'-deoxycytidine) enables precise reactivation of silenced tumor suppressor genes and enhances immunotherapy response through targeted DNA hypomethylation. This guide details advanced experimental workflows, protocol optimization, and troubleshooting strategies that leverage APExBIO’s Decitabine for robust cancer epigenetics research.

• Polyphosphazene Nanoparticles: Protein Delivery and Spermine

  2026-07-22

  This study pioneers the design of polyphosphazene-based nanoparticulate and soluble formulations for protein delivery, evaluating their performance at both molecular and cellular levels. The work demonstrates how spermine tetrahydrochloride enables efficient nanoparticle crosslinking and preserves protein function, providing key parameters for translational formulation strategies in biomedical research.

16414 records 1/1095 page Next 12345 下5页 Last page